TP63 and neoplasm: Compared to controls, tumor displaying lower SNAI1, PECAM1 and VIM and higher TP63, KRT14, KRT5 and PTPRC (CD45) RNAs (PyMT-VE-CadhSnail1KO tumor signature) presented a longer overall survival (Figure 7L), strengthen our mice results.